Clinical Trial Update: Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the atrophogenic potential of a triple combination cream for melasma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Snippet

Sponsor: Galderma R&D | Conditions: Melasma | Phase 4 | Status: COMPLETED